• Nenhum resultado encontrado

[PDF] Top 20 The prognostic value of phosphorylated AKT expression in non-small cell lung cancer: a meta-analysis.

Has 10000 "The prognostic value of phosphorylated AKT expression in non-small cell lung cancer: a meta-analysis." found on our website. Below are the top 20 most common "The prognostic value of phosphorylated AKT expression in non-small cell lung cancer: a meta-analysis.".

The prognostic value of phosphorylated AKT expression in non-small cell lung cancer: a meta-analysis.

The prognostic value of phosphorylated AKT expression in non-small cell lung cancer: a meta-analysis.

... into meta-analysis because the required data was available only in full ...source of bias is related to the method used to extrapolate the ...from the data included ... See full document

6

Plasminogen Activator Inhibitor-2 Plays a Leading Prognostic Role among Protease Families in Non-Small Cell Lung Cancer.

Plasminogen Activator Inhibitor-2 Plays a Leading Prognostic Role among Protease Families in Non-Small Cell Lung Cancer.

... considered the key molecule because it is the only member of the PA family shown to accelerate cell migration in ...vitro. In comparison, our IHC data demonstrated no ... See full document

15

MicroRNA-dependent regulation of transcription in non-small cell lung cancer.

MicroRNA-dependent regulation of transcription in non-small cell lung cancer.

... approaches the whole genome expression microarray data to minimize false ...gene expression levels by discriminate microarray data analysis and by the one-sample ...several of ... See full document

13

Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.

Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.

... including lung and breast cancer, and found that the propor- tion of cells that expressed ALDH1 was ...1.0% in CRC. Their study also showed that the ALDH1-positive population is ... See full document

15

Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis.

Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis.

... included in the final analysis, the average sample size was small ...contacted the corresponding author, but received no ...from the data or curves in these ... See full document

14

BRCA1: a novel prognostic factor in resected non-small-cell lung cancer.

BRCA1: a novel prognostic factor in resected non-small-cell lung cancer.

... gene expression. Qualitative variables were summarized by means of absolute frequencies and ...percentages. The Kruskal- Wallis test was used to check for normality. Differences in median mRNA ... See full document

7

The prognostic role of mTOR and p-mTOR for survival in non-small cell lung cancer: a systematic review and meta-analysis.

The prognostic role of mTOR and p-mTOR for survival in non-small cell lung cancer: a systematic review and meta-analysis.

... Lung cancer is the leading cause of cancer-related death all over the world during the past few ...years. Non-small cell lung cancer ... See full document

13

MicroRNA expression and clinical outcome of small cell lung cancer.

MicroRNA expression and clinical outcome of small cell lung cancer.

... Although expression of the 7 microRNAs in our study was evaluated in many cancer types in vitro, in vivo, and in tumor specimens, they have not been ... See full document

8

Pemetrexed plus platinum as the first-line treatment option for advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials.

Pemetrexed plus platinum as the first-line treatment option for advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials.

... finding of the present meta-analysis is that PPC improved OS homogenously and significantly, when compared with other PBR, with a 9% reduction in the risk of ...But ... See full document

8

Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

... determine the best cut-off value for LMR as a prognostic ...using the Kaplan-Meier method and the log-rank ...Spearman’s-Rho analysis was used to determine associ- ations between ... See full document

13

Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.

Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.

... from the initial ...criteria. The abstract of one paper, in which the authors stated that they had used tissue microarray and immunohistochemistry (IHC) to detect the ... See full document

13

Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis.

Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis.

... because the required data were usually available only in full ...source of bias is related to the method used to extrapolate the ...If the HR was not reported by author, it was ... See full document

8

Clinics  vol.68 número5

Clinics vol.68 número5

... occurs in cancer patients who are receiving ...with the degree of malnutrition and is a regularly used biomarker for long-term nutrition status ...by the liver and maintains ... See full document

8

Chemotherapy plus best supportive care versus best supportive care in patients with non-small cell lung cancer: a meta-analysis of randomized controlled trials.

Chemotherapy plus best supportive care versus best supportive care in patients with non-small cell lung cancer: a meta-analysis of randomized controlled trials.

... that the treatment with chemotherapy plus BSC yielded a statistically significant benefit in OS as compared with BSC ...subgroup analysis suggested that gemcitabine/vinorelbine therapy did not have ... See full document

9

Potential role of immunotherapy in advanced non-small-cell lung cancer

Potential role of immunotherapy in advanced non-small-cell lung cancer

... all the aspects discussed in this manuscript, it is noteworthy that immuno checkpoint inhibitors have estab- lished a new era for the treatment of advanced ...NSCLC. The large set ... See full document

10

J. bras. pneumol.  vol.36 número5 en v36n5a14

J. bras. pneumol. vol.36 número5 en v36n5a14

... for lung cancer has been modified since its first edition in the late ...for the first time, a truly worldwide database was analyzed in order to propose modifications in ... See full document

4

PDF EN Jornal Brasileiro de Pneumologia 5 14 english

PDF EN Jornal Brasileiro de Pneumologia 5 14 english

... practically the same five-year survival. Although these differences in survival were statistically significant, the findings could not be validated by geographic area because most of ... See full document

4

Whole brain radiotherapy plus concurrent chemotherapy in non-small cell lung cancer patients with brain metastases: a meta-analysis.

Whole brain radiotherapy plus concurrent chemotherapy in non-small cell lung cancer patients with brain metastases: a meta-analysis.

... met the following criteria were eligible: (1) randomized controlled trials (RCT) with voluntarily enrolled patients; (2) patients had histologically or cytologically confirmed NSCLC and had been diagnosed with ... See full document

6

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice

... determinated in plasma samples [70]. MiR- 126 inhibits the NSCLC cells proliferation via EGF-like domain-containing protein 7 (EGFL7) and targets Sdf-1 cytokine to reduce the recruitment of ... See full document

13

Incidence and imaging characteristics of skeletal metastases detected by bone scintigraphy in lung cancer patients

Incidence and imaging characteristics of skeletal metastases detected by bone scintigraphy in lung cancer patients

... Scintigrafija skeleta je standardna metoda nuklearne medicine koja se koristi za otkrivanje metastaza u kostima bolesnika obolelih od maligne bolesti. Sekundarni depoziti u kostima su u našoj grupi ispitanika ... See full document

5

Show all 10000 documents...